Practical Reviews

Tomosynthesis Shines in the Spotlight

Background: Traditional 2-view mammography has been shown to decrease mortality from breast cancer by identifying cancer before it becomes clinically apparent. Despite the benefits of mammography, some limitations continue, including limited sensitivity, false-positive results, and criticisms of overdiagnosis of lesions of uncertain potential behavior. In 2011, digital breast tomosynthesis was approved by the FDA to be used in combination with traditional 2-view mammography. Object more...
To view this content, you must be a logged in subscriber to
Please Login to view this content.